atenolol has been researched along with indapamide in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.63) | 18.7374 |
| 1990's | 3 (9.38) | 18.2507 |
| 2000's | 17 (53.13) | 29.6817 |
| 2010's | 7 (21.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Leonetti, G; Rappelli, A; Salvetti, A; Scapellato, L | 1 |
| Duman, EL; Komsuoğlu, B; Komsuoğlu, SS; Ozgür, O | 1 |
| De Divitiis, O; Di Somma, S; Fazio, S; Ligouri, V; Petitto, M | 1 |
| Zacharias, FJ | 1 |
| Allegri, M; Freggiaro, V; Magni, S; Stirace, T | 1 |
| Anania, V; Bartoli, E; Desole, MS; Faedda, R; Miele, E; Olmeo, NA; Satta, A; Soggia, G; Vacca, R | 1 |
| Amabile, G; Bory, M; De Luca, N; Denis, B; Imbs, JL; Lahiri, A; Marchegiano, R; Raftery, EB; Senior, R; Zannad, F | 1 |
| Bamrah, VS; Forbes, M; Kochar, MS; Kotecki, G; Trottier, D | 1 |
| Chastang, C; Mallion, JM; Unger, P | 1 |
| Asmar, RG; London, GM; O'Rourke, ME; Safar, ME | 1 |
| Asmar, R; Guérin, A; London, G; Pannier, B; Safar, M | 1 |
| London, GM | 1 |
| Khadipash, LA; Kiseleva, NV; Kosmatova, OV; Mamedov, MN; Oganov, RG; Perova, NV | 1 |
| Asmar, RG; London, GM; O'Rourke, MF; Safar, ME | 1 |
| Asmar, R; Battegay, E; Chamontin, B; De Leeuw, PW; Duprez, D; Hitzenberger, G; Mallion, JM; O'Brien, E; O'Rourke, MF; Rahn, KH; Romero, R; Safar, ME | 1 |
| Asmar, RG; de Luca, N; London, GM; O'Rourke, MF; Safar, ME | 1 |
| Battegay, E; De Leeuw, PW; de Luca, N; Duprez, D; Hitzenberger, G; Mallion, JM; O'Brien, E; O'Rourke, MF; Rahn, KH; Romero, R; Safar, ME; Sever, P; Trimarco, B | 1 |
| Amar, J; Chamontin, B; Ferrières, J; Mallion, JM; Peyrieux, JC; Ruidavets, JB; Safar, ME | 1 |
| Kremnev, IuA; Podshibiakin, SE; Zamotaev, IuN | 1 |
| Fournier, A; Safar, ME | 1 |
| Mourad, JJ; Waeber, B | 1 |
| Achimastos, A; Blacher, J; Protogerou, A; Safar, ME; Stergiou, GS | 1 |
| Ghiadoni, L; Kardasz, I; Magagna, A; Salvetti, A; Taddei, S | 1 |
| Dolan, E; Jin, Y; Li, Y; O'Brien, E; Protogerou, A; Richart, T; Safar, ME; Staessen, JA; Thijs, L; Wang, JG | 1 |
| Angeli, F; Reboldi, G; Verdecchia, P | 1 |
2 review(s) available for atenolol and indapamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Arterial stiffness, wave reflections and myocardial protection: the REASON project].
Topics: Antihypertensive Agents; Arteries; Atenolol; Blood Pressure; Diastole; Drug Combinations; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Systole | 2003 |
17 trial(s) available for atenolol and indapamide
| Article | Year |
|---|---|
Long-term effects of indapamide: final results of a two-year Italian multicenter study in systemic hypertension.
Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Diuretics; Drug Combinations; Drug Tolerance; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Indapamide; Italy; Lipoproteins; Male; Middle Aged; Multicenter Studies as Topic; Placebos; Potassium; Quality of Life | 1990 |
The effect of chronic antihypertensive therapy on the index of left ventricular mass in patients with essential hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiac Volume; Clinical Trials as Topic; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Prazosin; Random Allocation; Reserpine | 1989 |
Indapamide and atenolol in the treatment of hypertension: double-blind comparative and combination study.
Topics: Adult; Atenolol; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Random Allocation | 1983 |
A comparative study of the efficacy of indapamide and bendrofluazide given in combination with atenolol.
Topics: Antihypertensive Agents; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indapamide; Male; Propanolamines | 1981 |
Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; France; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Italy; Male; Middle Aged; Nifedipine; United Kingdom | 1993 |
Sequential monotherapy of hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Hypertension; Indapamide; Male; Middle Aged | 1994 |
Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Safety; Treatment Outcome | 2000 |
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aorta; Arteries; Asthenia; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Cough; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Follow-Up Studies; Headache; Heart Rate; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Pulse; Treatment Outcome | 2001 |
[Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study].
Topics: Atenolol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Indapamide; Patient Selection; Perindopril; Systole; Time Factors | 2002 |
[Arterial stiffness, wave reflections and myocardial protection: the REASON project].
Topics: Antihypertensive Agents; Arteries; Atenolol; Blood Pressure; Diastole; Drug Combinations; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Systole | 2003 |
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril | 2004 |
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diastole; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Heart Rate; Humans; Hypertension; Incidence; Indapamide; Male; Middle Aged; Perindopril; Systole; Treatment Outcome | 2004 |
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome; Ultrasonography | 2004 |
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Drug Therapy, Combination; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril | 2004 |
Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Topics: Aged; Antihypertensive Agents; Aortic Diseases; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Predictive Value of Tests; Pulse; Treatment Outcome | 2009 |
Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients.
Topics: Adult; Antihypertensive Agents; Atenolol; Brachial Artery; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Nitroglycerin; Perindopril; Vasodilation | 2009 |
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Double-Blind Method; Drug Therapy, Combination; Elasticity; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2011 |
14 other study(ies) available for atenolol and indapamide
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Clinical results of the combined use of a diuretic and a beta-blocking agent in the therapy of arterial hypertension].
Topics: Aged; Atenolol; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Propanolamines | 1982 |
[Evaluation of the combination of atenolol and indapamide in the therapy of arterial hypertension (with data concerning toxicity and tolerance in the experimental animal)].
Topics: Adult; Aged; Animals; Atenolol; Blood Pressure; Body Weight; Diuretics; Dogs; Drug Therapy, Combination; Electrolytes; Female; Hemodynamics; Humans; Hypertension; Indapamide; Male; Middle Aged; Propanolamines; Rats | 1981 |
[Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome].
Topics: Adult; Antihypertensive Agents; Atenolol; Atorvastatin; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Female; Fenofibrate; Heptanoic Acids; Humans; Hypolipidemic Agents; Indapamide; Male; Metabolic Syndrome; Middle Aged; Perindopril; Pyrroles; Simvastatin; Treatment Outcome | 2003 |
C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; C-Reactive Protein; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Predictive Value of Tests; Retrospective Studies; Treatment Outcome | 2005 |
[Cardiac glycosides in complex treatment of patients with heart failure and supraventricular arrhythmias].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atenolol; Blood Pressure; Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Echocardiography; Electrocardiography; Enalapril; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Indapamide; Lanatosides; Male; Middle Aged; Tachycardia, Supraventricular; Treatment Outcome | 2005 |
Letter by Safar and Fournier regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Indapamide; Perindopril; Proportional Hazards Models; Reproducibility of Results; Stroke Volume; Treatment Outcome | 2006 |
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension.
Topics: Antihypertensive Agents; Aorta; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Drug Therapy, Combination; Elasticity; Humans; Hypertension; Indapamide; Perindopril; Risk Factors; Treatment Outcome | 2011 |